Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis.
Saved in:
| Title: | Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. |
|---|---|
| Authors: | Situ M; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada., Schwarz UI; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Zou G; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada.; Alimentiv Inc, London, ON, Canada., McArthur E; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada., Kim RB; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Garg AX; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Sarma S; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada. ssarma2@uwo.ca.; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada. ssarma2@uwo.ca.; Lawson Health Research Institute, London, ON, Canada. ssarma2@uwo.ca. |
| Source: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Apr; Vol. 25 (3), pp. 397-409. Date of Electronic Publication: 2023 May 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1618-7601 |
|---|---|
| DOI: | 10.1007/s10198-023-01594-7 |
